is semaglutide and saxenda the same thing Wegovy vs. Saxenda: Comparing Two Weight-Loss Injections Ozempic vs. Mounjaro vs. Saxenda:

GLP-1 receptor agonists show robust neuroprotection in stroke models, yet human clinical benefits remain uncertain so far

Summary: Retatrutide phase 2 trial data in type 2 diabetes showed dose-dependent weight loss of up to approximately 16.9% from baseline at 24 weeks with the 12 mg dose, alongside substantial HbA1c reductions

This information is intended for educational purposes and should not replace professional medical advice or evaluation

A 2024 study published in JAMA Ophthalmology reported that patients with Type 2 diabetes who took semaglutide-containing medications had more than a fourfold higher risk for developing non-arteritic anterior ischemic optic neuropathy (NAION) compared with patients not on a GLP-1 agonist

Beneficial effects of pharmacotherapy on weight loss, depressive symptoms, and eating patterns in obese binge eaters and non-binge eaters